LivaNova

LivaNova

LivaNova is a global medical technology company developing and manufacturing cardiovascular and neuromodulation solutions.

LivaNova is a global medical technology company developing and manufacturing cardiovascular and neuromodulation solutions. The company was founded in 2015 during a merger between Cyberonics and Sorin Group. Headquartered in London, England, LivaNova has a presence in more than 100 countries with a workforce of more than 3,500 employees worldwide. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol “LIVN.”

Cardiovascular

LivaNova's advanced cardiovascular solutions include the only sutureless valve for aortic surgery and advanced temporary cardiopulmonary support systems that include extracorporeal life support and percutaneous mechanical circulatory support.

Neuromodulation

LivaNova pioneered the VNS (Vagus Nerve Stimulation) Therapy System and continue to advance medical device solutions for people affected by drug-resistant epilepsy and difficult-to-treat depression. The VNS system is being studied to validate its ability to deliver Autonomic Regulation Therapy for heart failure. Livanova also treats obstructive sleep apnea (OSA) with an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, opening the airway while a patient is sleeping.

COVID-19

Due to the outbreak of the novel COVID-19 (coronavirus), personal protective equipment and specifically respirators have increased in demand as shortages have occurred in health environments and hospitals. LivaNova looks to remain operational during the pandemic. They continue to supply multiple countries in combating the virus.

Timeline

2015

LivaNova was founded.

People

Name
Role
LinkedIn

Damien McDonald

CEO

Further reading

Title
Author
Link
Type
Date

Cyberonics And Sorin Group To Merge, Creating A New Premier Global Medical Technology Company

Cyberonics Inc.

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
May 20, 2020
BioSpace
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the publication of a new study in the International Journal of Bipolar Disorders 1 that showed adding Vagus Nerve Stimulation Therapy (VNS Therapy ® ) to treatment as usual (TAU) significantly improves outcomes in patients with treatment-resistant bipolar depression (TRBD). The study examined patients from a five-year prospec
May 19, 2020
BioSpace
LivaNova to Present PERSIST-AVR Findings at American Association for Thoracic Surgery 100th Annual Meeting - read this article along with other careers information, tips and advice on BioSpace
Fink Densford
February 27, 2019
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice
Fink Densford
February 21, 2019
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice
February 19, 2019
WebWire
Rahf AlRashidi is proud to present in Kindle the first edition of her eagerly anticipated debut work, ' The Clouds Beyond Us '. This beautifully crafted, breaking-the-mould book presents an eclectic mix of poetry and short heart-inspired musings, as penned by the author at various points in her young life. It is, in essence, a collection of insights into the writer's soul, and allows the reader to accompany her on what is a journey of heartache, ill treatment and loss, whilst simultaneo...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.